Evidence map›Paper›PMID 39877124›Full record

ArticleEnvironmental science & technology letters2024

Microbial Treatment Targets for Potable and Nonpotable Water Reuse - A Comprehensive Update and Harmonization.

Michael A Jahne, Mary E Schoen, Jay L Garland, Sharon P Nappier, Jeffrey A Soller

Abstract read
In one paragraph

Article in Environmental science & technology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael A JahneUnited States and DevelopmentEnvironmental Protection Agency, Cincinnati, Ohio 45268, United States.ORCID 0000-0002-4741-9859
Mary E SchoenSoller Environmental, Berkeley, California 94703, United States.ORCID 0000-0002-2837-3517
Jay L GarlandUnited States and DevelopmentEnvironmental Protection Agency, Cincinnati, Ohio 45268, United States.
Sharon P NappierUnited States Environmental Protection Agency, Office of Water, Office of Science and Technology, Washington, D.C. 20460, United States.ORCID 0000-0001-7082-8784
Jeffrey A SollerSoller Environmental, Berkeley, California 94703, United States.ORCID 0000-0003-3069-2653

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

Increasing pressures on traditional sources of water have accelerated the adoption of water reuse throughout the world. A key consideration for communities pursuing water reuse is understanding the amount of treatment that is needed to ensure adequate human health protection. Several U.S. EPA documents describe the importance of managing acute microbial risks and highlight the utility of quantitative microbial risk assessment for developing "fit-for-purpose" treatment targets based on the source of water and end-use. However, there are no U.S. federal water reuse regulations and states are currently considering microbial treatment targets for various applications. Previous publications have yet to address this need by using an updated and consistent set of input parameters to present risk-based microbial treatment targets across a wide range of sources of water, end-use applications, and health benchmarks. This work combines the most current modeling inputs and dose-response parameter values to provide probability of infection and disease burden-based microbial treatment targets for untreated municipal wastewater, untreated onsite wastewater, graywater, stormwater, and roof runoff water used for potable reuse, indoor nonpotable use, and landscape irrigation applications.

Indexed as

log reductionnonpotablepotableQMRArisk assessmentwater reuse

Identifiers

PMID39877124
PMCPMC11770559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.